Bioresorbable medical material market seen reaching $2.77 billion by 2030

The global market for bioresorbable medical materials is projected to grow from $1.71 billion in 2025 to $1.88 billion in 2026, with demand rising across surgical implants and regenerative medicine. North America led in 2025, while Asia-Pacific is expected to grow fastest through 2030.

Why it matters: - Bioresorbable medical materials reduce the need for follow-up surgery because the body absorbs or breaks down the material over time. - The market outlook points to broader use in implants, scaffolds and drug-delivery devices as healthcare shifts toward minimally invasive and regenerative treatments. - Faster adoption could lower complication risk and support recovery in procedures that currently rely on permanent implants.

What happened: - The Business Research Company released its Bioresorbable Medical Material Global Market Report 2026 – Market Size, Trends, And Forecast 2026-2035. - The report values the market at $1.71 billion in 2025 and forecasts $1.88 billion in 2026. - The report projects the market will reach $2.77 billion by 2030. - The report was published Nov. 6, 2026, in London. - A free sample of the report is available online. - The full market report is also available online.

The details: - The market is projected to grow at a 9.9% CAGR in 2026. - The report forecasts a 10.1% CAGR through 2030. - Growth in the past years has been driven by greater use of biodegradable polymers in medical devices. - Other drivers include more surgical implant procedures, stronger demand for minimally invasive therapies, progress in polymer chemistry and broader biomedical research. - The report cites regenerative medicine, next-generation implant materials, personalized medical devices and tissue engineering investments as key future growth drivers. - Emerging trends include bioresorbable polymer implants, temporary medical implants, advanced tissue engineering scaffolds, drug-eluting bioresorbable devices and controlled-degradation materials. - Bioresorbable medical materials are designed to be safely absorbed or broken down by the human body over time. - These materials are used in surgical implants and tissue engineering scaffolds. - The materials remove the need for surgical retrieval once their job is done. - The report says the materials can reduce patient risk and support tissue regeneration. - The report says they can also minimize complications tied to long-term foreign bodies. - Surgical procedures are a major demand driver because bioresorbable polymers are used in equipment for neurology, orthopedics and cosmetic surgery. - Common products include sutures, anchors and screws that dissolve after healing. - ISAPS data cited in the report showed almost 35 million aesthetic procedures in the United States in 2023. - That figure represented a 3.4% increase to 34.9 million combined surgical and non-surgical treatments in 2023. - North America held the largest share of the market in 2025. - Asia-Pacific is expected to be the fastest-growing region over the coming years. - The report covers Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East and Africa.

Between the lines: - The forecast suggests the category is moving from a niche materials segment toward a broader platform for temporary and regenerative medical products. - The emphasis on avoiding secondary surgeries points to cost and patient-recovery pressures shaping device design. - Regional leadership in North America and faster growth in Asia-Pacific suggest a market that is both established and still expanding geographically.

What's next: - The report points to continued expansion as regenerative medicine and tissue engineering move into more commercial use. - Demand is likely to rise for materials that can degrade in a controlled way while maintaining performance long enough to support healing. - The business strategy focus appears to be on product differentiation through advanced scaffolds, implant materials and drug-eluting designs. - The company also highlighted updated 2026 report features, including TAM analysis, company scoring matrices, Excel dashboards, hotspots infographics and updated graphics and tables.

The bottom line: - Bioresorbable medical materials are set for steady double-digit growth as surgery, regenerative medicine and implant innovation push healthcare toward temporary, body-absorbed alternatives.